Imaging-based prediction of hepatocellular carcinoma recurrence after microwave ablation as bridge therapy: A glimpse into the future

doi:10.5500/wjt.v14.i4.98653

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (320)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

248

Sum=258

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=47

Dec 18, 2024 (publication date) through Oct 5, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Transplant. Dec 18, 2024; 14(4): 98653
Published online Dec 18, 2024. doi: 10.5500/wjt.v14.i4.98653

Imaging-based prediction of hepatocellular carcinoma recurrence after microwave ablation as bridge therapy: A glimpse into the future

Cristian Lindner, Rodrigo San Martín, Andrés Concha, David Clemo, Jorge Valenzuela

Cristian Lindner, Rodrigo San Martín, Andrés Concha, Jorge Valenzuela, Department of Radiology, Faculty of Medicine, University of Concepción, Concepción 4030000, Chile

Cristian Lindner, Rodrigo San Martín, Andrés Concha, David Clemo, Jorge Valenzuela, Department of Radiology, Hospital Regional Guillermo Grant Benavente, Concepción 4030000, Biobío, Chile

Author contributions: Lindner C designed the overall concept and outline of the manuscript; San Martín R, Concha A, Clemo D, and Valenzuela J contributed to data acquisition, drafting, and revising the manuscript; All authors contributed to the original ideas and writing of this paper.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Cristian Lindner, MD, Doctor, Department of Radiology, Faculty of Medicine, University of Concepción, No. 1290 Victor Lamas, Concepción 4030000, Chile. clindner@udec.cl

Received: July 1, 2024
Revised: July 16, 2024
Accepted: August 8, 2024
Published online: December 18, 2024
Processing time: 80 Days and 11.7 Hours

Core Tip

Core Tip: Microwave ablation (MWA) is a locoregional treatment used as bridge therapy to prevent tumor progression in patients with hepatocellular carcinoma (HCC) within the Milan criteria for liver transplantation. Growing evidence suggests that MWA provides technical advantages over other ablative techniques and offers lower complication rates compared to surgical resection. Accurate and timely detection of recurrence remains an unresolved challenge due to high rates of HCC tumor recurrence after ablative therapies. Recent advances in imaging-based assessments have shown promising results that could help predict tumor recurrence after MWA, thereby improving the management and prognosis of patients with HCC awaiting liver transplantation.